Use of Herpes Simplex Virus Thymidine Kinase to Improve the Antiviral Activity of Zidovudine

This publication has 22 references indexed in Scilit:

• A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
  New England Journal of Medicine, 1996
• Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
  The Lancet, 1996
• Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
  New England Journal of Medicine, 1996
• Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protectsacyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription
  Virology, 1995
• Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.
  Proceedings of the National Academy of Sciences, 1993
• Inhibition of mammalian dna polymerase-associated 3′ to 5′ exonuclease activity by 5′-monophosphates of 3′-azido-3′-deoxythymidine and 3′-amino-3′-deoxythymidine
  Biochemical Pharmacology, 1993
• Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population.
  Proceedings of the National Academy of Sciences, 1992
• Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′‐dideoxycytidine (ddc)
  Muscle & Nerve, 1989
• The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species
  Biochemical Pharmacology, 1988
• Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
  Proceedings of the National Academy of Sciences, 1986